Lixte Biotechnology Holdings
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-0.64-0.81-0.52-0.87-4.27-3.17-10.95-2.38-0.12-0.88N/A-4.27
Price/Sales ratio
N/A11.68N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
6.687.485.191.582.203.127.133.340.151.12N/A3.12
Price/Cash Flow ratio
-1.08-1.07-0.66-1.11-6.03-4.53-16.77-3.87-0.17-1.04N/A-6.03
Price/Free Cash Flow ratio
-1.08-1.07-0.66-1.11-6.03-4.53-16.77-3.87-0.17-1.04N/A-6.03
Price/Earnings Growth ratio
-0.000.380.010.03-0.341.73-0.31-0.03-0.000.00N/A-0.34
Dividend Yield
N/A0.08%0.17%N/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/A100%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/A-1323.20%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/A-1426.05%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/A-1426.05%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
0.00%0.00%0.1%0.10%0.46%2.03%0.04%-0.10%0.12%N/AN/A2.03%
Return on Assets
-512.92%-476.96%-492.54%-132.18%-49.18%-89.46%-62.41%-132.23%-113.39%-118.06%-171.14%-89.46%
Return On Equity
-1040.46%-913.16%-994.00%-181.74%-51.70%-98.21%-65.11%-140.59%-122.06%-127.34%-168.85%-98.21%
Return on Capital Employed
-903.90%-847.30%-994.09%-181.88%-51.82%-102.29%-65.17%-140.29%-122.19%-127.42%-184.15%-102.29%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A14.08N/A
Quick Ratio
1.971.881.983.6620.5511.2324.1416.8114.0813.7213.5611.23
Cash ratio
0.160.080.913.5020.2510.9223.4115.9213.5613.3913.5610.92
Days of Sales Outstanding
N/A365N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.07N/A
Debt Equity Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.07N/A
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-792.91N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Company Equity Multiplier
2.021.912.011.371.051.091.041.061.071.071.071.05
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/A-10.90N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
111111111111
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Dividend Payout Ratio
N/A-0.07%-0.09%N/AN/AN/AN/AN/AN/AN/AN/AN/A